RIZZOLIO, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.796
AS - Asia 11.475
EU - Europa 7.814
SA - Sud America 1.102
AF - Africa 235
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 20
Totale 45.465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.276
CN - Cina 3.640
SG - Singapore 3.369
IT - Italia 2.128
VN - Vietnam 1.624
PL - Polonia 1.505
BR - Brasile 909
HK - Hong Kong 863
DE - Germania 706
IE - Irlanda 659
UA - Ucraina 556
SE - Svezia 467
GB - Regno Unito 453
JP - Giappone 419
FR - Francia 393
CA - Canada 372
KR - Corea 356
IN - India 330
RU - Federazione Russa 260
FI - Finlandia 195
TR - Turchia 174
BD - Bangladesh 124
AT - Austria 90
ES - Italia 90
ID - Indonesia 90
MX - Messico 85
IQ - Iraq 83
NL - Olanda 79
ZA - Sudafrica 73
PK - Pakistan 63
PH - Filippine 60
AR - Argentina 56
BE - Belgio 49
EC - Ecuador 45
TH - Thailandia 45
IR - Iran 42
BJ - Benin 33
CH - Svizzera 33
MA - Marocco 33
UZ - Uzbekistan 33
TW - Taiwan 29
JO - Giordania 24
VE - Venezuela 24
LT - Lituania 23
CO - Colombia 22
CL - Cile 19
GR - Grecia 19
AU - Australia 18
KE - Kenya 18
SA - Arabia Saudita 18
EU - Europa 17
EG - Egitto 14
BG - Bulgaria 13
CZ - Repubblica Ceca 13
AE - Emirati Arabi Uniti 12
DZ - Algeria 12
PT - Portogallo 12
CR - Costa Rica 11
PY - Paraguay 11
AL - Albania 10
DK - Danimarca 10
RO - Romania 10
TN - Tunisia 9
MY - Malesia 8
NG - Nigeria 8
SI - Slovenia 8
JM - Giamaica 7
KZ - Kazakistan 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HN - Honduras 6
HR - Croazia 6
IL - Israele 6
NP - Nepal 6
SN - Senegal 6
TT - Trinidad e Tobago 6
LB - Libano 5
NZ - Nuova Zelanda 5
OM - Oman 5
RS - Serbia 5
AM - Armenia 4
AZ - Azerbaigian 4
BH - Bahrain 4
GE - Georgia 4
GT - Guatemala 4
LR - Liberia 4
NI - Nicaragua 4
NO - Norvegia 4
PA - Panama 4
PE - Perù 4
QA - Qatar 4
UY - Uruguay 4
AO - Angola 3
BN - Brunei Darussalam 3
HU - Ungheria 3
KH - Cambogia 3
MM - Myanmar 3
PR - Porto Rico 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 45.409
Salva come PNG Salva come JPEG
Città #
Ashburn 3.340
Woodbridge 3.154
Fairfield 2.164
Singapore 1.755
Warsaw 1.493
Chandler 1.391
Houston 1.157
Ann Arbor 1.154
Dallas 1.039
San Jose 1.032
Council Bluffs 998
Seattle 957
Jacksonville 860
Hong Kong 822
Cambridge 718
Wilmington 678
Dublin 592
Ho Chi Minh City 451
Hanoi 393
Beijing 346
New York 325
Jinan 318
Boardman 317
Seoul 316
Tokyo 313
Mestre 284
Venice 272
Nanjing 260
Los Angeles 255
Dearborn 228
Shenyang 224
Columbus 218
Guangzhou 203
Venezia 196
The Dalles 187
Andover 184
Boston 173
Hefei 161
San Mateo 151
Mülheim 149
Santa Clara 141
Hebei 139
Lauterbourg 139
Toronto 139
Izmir 129
Princeton 129
Ottawa 119
San Diego 119
Munich 115
Hangzhou 104
São Paulo 101
Changsha 97
Tianjin 97
Zhengzhou 96
Frankfurt am Main 95
Milan 95
Helsinki 92
Nanchang 89
Orem 86
Bengaluru 85
Taizhou 83
Altamura 81
Haikou 77
Jakarta 74
Da Nang 72
Padova 72
Taiyuan 71
London 70
Buffalo 66
Haiphong 66
Chicago 60
Ningbo 60
Vienna 55
Jiaxing 54
Johannesburg 50
San Paolo di Civitate 50
Brooklyn 48
Brussels 46
Redondo Beach 45
Moscow 43
Nuremberg 43
Chennai 42
Redwood City 42
Montreal 40
Pune 40
Fuzhou 39
Phoenix 39
Des Moines 38
Atlanta 37
Shanghai 37
North Bergen 35
Cotonou 33
Rome 33
Washington 33
Amsterdam 32
Rio de Janeiro 32
Memphis 31
Menlo Park 31
Denver 30
Saint Petersburg 28
Totale 33.392
Salva come PNG Salva come JPEG
Nome #
Bottom-Up Synthesis of Carbon Nanoparticles with Higher Doxorubicin Efficacy 630
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 580
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 580
Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications 528
Highly conserved non-coding sequences and the 18q critical region for short stature: A common mechanism of disease? 489
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 486
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activity on human ovarian cancer cell lines 469
Glucose Detection Devices and Methods Based on Metal–Organic Frameworks and Related Materials 465
pRb controls estrogen receptor alpha protein stability and activity 459
A guide to PIN1 function and mutations across cancers 455
Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer Cells 452
The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine 451
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients 449
Carbon-dots from sugars and ascorbic acid: Role of the precursors on morphology, properties, toxicity and drug uptake 448
Hyaluronan esters drive smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 440
Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer 435
An effective multi-stage liposomal DNA origami nanosystem for in vivo cancer therapy 430
Recent advances of electrochemical and optical enzyme-free glucose sensors operating at physiological conditions 429
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor 423
Palladacyclopentadienyl complexes bearing purine-based N-heterocyclic carbenes: A new class of promising antiproliferative agents against human ovarian cancer 421
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 413
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 413
Self-Therapeutic Nanomaterials for Cancer Therapy: A Review 413
DNA nanotechnology for cancer therapy 410
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 404
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research 399
The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer 399
Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands 396
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer 393
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin 390
Androgen receptor serine 81 mediates Pin1 interaction and activity 379
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 378
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) 365
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 341
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 341
MTHFR-1298 A > C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 339
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines 338
The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes 337
Adenosine receptor ligands in clinical trials 335
A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28 330
Identification and characterization of a new reversible MAGL inhibitor 328
Allyl palladium complexes bearing carbohydrate-based N-heterocyclic carbenes: Anticancer agents for selective and potent in vitro cytotoxicity 328
Epigenetic analysis of the critical region I for premature ovarian failure: Demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome 327
A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males 327
Improved Synthesis, Anticancer Activity and Electrochemical Characterization of Unusual Zwitterionic Palladium Compounds with a Ten‐Term Coordinative Ring 324
Highly Selective Salicylketoxime-Based Estrogen Receptor beta Agonists Display Antiproliferative Activities in a Glioma Model 323
Supercritical CO2 extraction of natural antibacterials from low value weeds and agro-waste 322
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 316
Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 315
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin 314
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 313
Pin1 and nuclear receptors: A new language? 310
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 308
Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells 308
Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls 308
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors 302
Chromosomal rearrangements in Xq and premature ovarian failure: Mapping of 25 new cases and review of the literature 301
Cyclic Ketoximes as Estrogen Receptor Selective Agonists 301
Metabolomics biomarkers of frailty in elderly breast cancer patients 300
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 298
RB gene family: Genome-wide ChIP approaches could open undiscovered roads 297
Synthesis and Antimicrobial Evaluation of Bis-morpholine Triazine Quaternary Ammonium Salts 297
Dissecting Pin1 and phospho-pRb regulation 295
X chromosome and ovarian failure 295
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt's lymphoma cell lines 294
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 293
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 292
Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells 290
Upconversion-mediated Boltzmann thermometry in double-layered Bi2SiO5:Yb3+,Tm3+@SiO2hollow nanoparticles 290
STARD3: A Prospective Target for Cancer Therapy 289
CDK inhibitors: from the bench to clinical trials 288
Palladium(II)-η3-Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids 286
Critical choices for modeling breast cancer in transgenic mouse models 285
Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: A hypothesis 282
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models 282
Fluorescent carbon nanoparticles in medicine for cancer therapy 280
Pharmaco-metabolomics: An emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets 278
2D metal azolate framework as nanozyme for amperometric detection of glucose at physiological pH and alkaline medium 278
Fluorescent molecularly imprinted nanogels for the detection of anticancer drugs in human plasma 277
Spatial and temporal expression of POF1B, a gene expressed in epithelia 277
Nanomedicine in cancer pathology 276
Emerging molecular networks in Burkitt's lymphoma 271
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 271
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease 268
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 267
Identification of new fyn kinase inhibitors using a FLAP-based approach 265
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 265
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 265
Research highlights. Overcoming BRAF resistance to PLX4032 by AKT inhibition in PTEN-deficient melanoma cells 261
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors 260
Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update 260
Cancer extracellular vesicles: Next-generation diagnostic and drug delivery nanotools 256
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B 255
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor 255
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer 251
Application of MM-PBSA methods in virtual screening 251
Synthesis and comparative study of the anticancer activity of η3-allyl palladium(II) complexes bearing N-heterocyclic carbenes as ancillary ligands 248
Microfluidic organoids‐on‐a‐chip: Quantum leap in cancer research 242
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer 240
Inorganic Nanoparticles for Cancer Therapy: a Transition from Lab to Clinic 240
Totale 34.217
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.548
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.040 344 591 330 625 383 40 221 194 97 740 1.014 461
2022/20233.883 297 384 68 445 366 1.110 50 284 482 32 291 74
2023/20241.937 103 110 72 91 261 443 63 124 216 48 190 216
2024/20253.755 59 98 262 280 299 228 441 398 446 425 546 273
2025/202615.476 961 736 1.707 976 1.597 1.082 2.075 812 2.061 1.602 663 1.204
2026/2027392 392 0 0 0 0 0 0 0 0 0 0 0
Totale 46.178